GGrantIndex
Sort

1,049,261 grants matching t cell

Developing Pluripotent Stem Cells to Model and Treat Lung Disease

$2,941,211
Darrell N. Kotton · Boston University Medical Campus · P01 · FY2024 · HL

Metabolic factors that control the spectrum of human tuberculosis

$2,941,042
David Branch Moody · Brigham And Women'S Hospital · U19 · FY2020 · AI

SPORE IN PROSTATE CANCER

$2,940,900
University Of Michigan At Ann Arbor · P50 · FY2001 · CA

Penn Center for AIDS Research

$2,940,869
Ronald G Collman · University Of Pennsylvania · P30 · FY2024 · AI

Microbiota and Allergic Asthma Precision Prevention (MAAP2)

$2,940,814
Christine C Johnson · Henry Ford Health System · P01 · FY2020 · AI

Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain

$2,940,765
Zhigang David Luo · University Of California-Irvine · R01 · FY2019 · DE

Multicenter Aids Cohort Study- Part B (Baltimore Site)

$2,940,619
Joseph B. Margolick · Johns Hopkins University · U01 · FY2006 · AI

Dual targeting of tumoral microenvironment and tumoral cells by blocking the IL-33/ST2 pathway

$2,940,474
Sophie Paczesny · Medical University Of South Carolina · U01 · FY2018 · CA

Sirtuins and nuclear receptors in aging and age-associated diseases

$2,940,311
Xiaoling Li · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES

Lead Optimization and Preclinical Development of Human Nicotine-Specific mAbs

$2,939,717
Matthew W Kalnik · Antidote Therapeutics, Inc. · R01 · FY2016 · DA

Molecular And Pharmacological Studies Of Dopamine Receptors

$2,939,543
David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS

HIGH EFFICIENCY, LATTICE-MATCHED SOLAR CELLS USING EPITAXIAL LIFT-OFF

$2,939,403
Microlink Devices Inc · · FY2013 · Department of Energy

Structural Cell Biology of DNA Repair Machines

$2,939,283
John A Tainer · University Of Calif-Lawrenc Berkeley Lab · P01 · FY2015 · CA

WormBase: a core data resource for C. elegans and other nematodes

$2,939,165
Paul Warren Sternberg · California Institute Of Technology · U41 · FY2016 · HG

ID-CTP Clinical Core

$2,939,106
Sung-Yun Pai · Division Of Basic Sciences - Nci · ZID · FY2024 · CA

An AAV-mediated functional cure and its impact on the reservoir

$2,938,902
Michael R. Farzan · Scripps Florida · U19 · FY2020 · AI

PEDIATRIC PRECLINICAL TESTING PROGRAM

$2,938,868
Peter J Houghton · Research Inst Nationwide Children'S Hosp · N01 · FY2010 · CA

Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART

$2,938,698
Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2016 · AI

Host cell reprogramming by human papillomavirus E7 proteins

$2,938,414
Elizabeth A White · Tufts University Boston · R01 · FY2025 · AI

A Tolerance Approach to Xenotransplantation

$2,938,083
David H Sachs · Columbia University Health Sciences · P01 · FY2015 · AI

A Tolerance Approach to Xenotransplantation

$2,938,062
David H Sachs · Massachusetts General Hospital · P01 · FY2014 · AI

Development of a Potent and Highly Selective NaV1.7 Inhibitor for the Treatment of Acute Pain with the Goal of Reducing Opioid Use and Preventing Opioid Use Disorders

$2,937,963
John Cureton Hunter · Siteone Therapeutics, Inc. · UG3 · FY2019 · DA

Protein homeostasis mechanisms underlying enterovirus replication and evolution

$2,937,748
Raul Andino · University Of California, San Francisco · P01 · FY2011 · AI

Investigating regional and cellular vulnerabilities to tau pathology in young-onset Alzheimer's disease

$2,937,723
Melissa Erin Murray · Mayo Clinic Jacksonville · R01 · FY2025 · AG

Center for Adolescent Reward, Rhythms and Sleep (CARRS)

$2,937,638
Colleen A McClung · University Of Pittsburgh At Pittsburgh · P50 · FY2021 · DA